Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685)
机构：[1]Guandong Gen Hosp, Guangzhou, Guangdong, Peoples R China广东省人民医院[2]Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China[3]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China中山大学附属第二医院[4]Peking Univ Canc Hosp & Inst, Beijing, Peoples R China[5]Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China昆明医科大学附属第一医院[6]Nanjing Mil Command, Nanjing Gen Hosp, Nanjing, Jiangsu, Peoples R China[7]Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China[8]Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China浙江大学医学院附属第一医院[9]Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China浙江省肿瘤医院[10]Anhui Prov Hosp, Hefei, Anhui, Peoples R China[11]Harbin Med Univ, Harbin, Peoples R China
第一作者机构：[1]Guandong Gen Hosp, Guangzhou, Guangdong, Peoples R China[2]Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China[3]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China[4]Peking Univ Canc Hosp & Inst, Beijing, Peoples R China[5]Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China[6]Nanjing Mil Command, Nanjing Gen Hosp, Nanjing, Jiangsu, Peoples R China[7]Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China[8]Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China[9]Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China[10]Anhui Prov Hosp, Hefei, Anhui, Peoples R China[11]Harbin Med Univ, Harbin, Peoples R China
推荐引用方式(GB/T 7714)：
Lin Feng,Li Guoxin,Chu Zhonghua,et al.Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685)[J].JOURNAL OF CLINICAL ONCOLOGY.2015,33(3):doi:10.1200/jco.2015.33.3_suppl.777.
APA：
Lin, Feng,Li, Guoxin,Chu, Zhonghua,Hao, Chunyi,Chen, Mingqing...&Wang, Xishan.(2015).Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685).JOURNAL OF CLINICAL ONCOLOGY,33,(3)
MLA：
Lin, Feng,et al."Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685)".JOURNAL OF CLINICAL ONCOLOGY 33..3(2015)
医学